81 related articles for article (PubMed ID: 18751387)
21. Adenovirus-mediated antisense ATM gene transfer sensitizes prostate cancer cells to radiation.
Fan Z; Chakravarty P; Alfieri A; Pandita TK; Vikram B; Guha C
Cancer Gene Ther; 2000 Oct; 7(10):1307-14. PubMed ID: 11059687
[TBL] [Abstract][Full Text] [Related]
22. Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer.
Carstens RP; Eaton JV; Krigman HR; Walther PJ; Garcia-Blanco MA
Oncogene; 1997 Dec; 15(25):3059-65. PubMed ID: 9444954
[TBL] [Abstract][Full Text] [Related]
23. Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression.
Kyprianou N; Rock S
Anticancer Res; 1998; 18(2A):897-905. PubMed ID: 9615738
[TBL] [Abstract][Full Text] [Related]
24. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
25. Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells.
Wendt J; Radetzki S; von Haefen C; Hemmati PG; Güner D; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2006 Feb; 25(7):972-80. PubMed ID: 16331277
[TBL] [Abstract][Full Text] [Related]
26. Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin.
Bull EE; Dote H; Brady KJ; Burgan WE; Carter DJ; Cerra MA; Oswald KA; Hollingshead MG; Camphausen K; Tofilon PJ
Clin Cancer Res; 2004 Dec; 10(23):8077-84. PubMed ID: 15585643
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation.
Rosini P; Bonaccorsi L; Baldi E; Chiasserini C; Forti G; De Chiara G; Lucibello M; Mongiat M; Iozzo RV; Garaci E; Cozzolino F; Torcia MG
Prostate; 2002 Dec; 53(4):310-21. PubMed ID: 12430142
[TBL] [Abstract][Full Text] [Related]
29. Prostate specific antigen gene expression in androgen insensitive prostate carcinoma subculture cell line.
Tsui KH; Feng TH; Chung LC; Chao CH; Chang PL; Juang HH
Anticancer Res; 2008; 28(4A):1969-76. PubMed ID: 18649734
[TBL] [Abstract][Full Text] [Related]
30. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
31. FGFR3-expressing smooth muscle-like stromal cells differentiate in response to FGFR2IIIb-expressing prostate tumor cells and delay tumor progression.
Jin C; Yang C; Wu X; Wang F; McKeehan WL
In Vitro Cell Dev Biol Anim; 2011 Aug; 47(7):500-5. PubMed ID: 21691921
[TBL] [Abstract][Full Text] [Related]
32. Radiation- and heat-induced apoptosis in PC-3 prostate cancer cells.
Li WX; Franklin WA
Radiat Res; 1998 Aug; 150(2):190-4. PubMed ID: 9692364
[TBL] [Abstract][Full Text] [Related]
33. [Effect of p53-regulated apoptosis-inducing protein 1 transfection on the biological characteristics of PC-3M human prostate cancer cells].
Lin X; Zhao Q; Yin X; Tian R; Li F; Gao J; Yu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):819-23. PubMed ID: 25108434
[TBL] [Abstract][Full Text] [Related]
34. Response of PC-3 prostate cancer cells to combination therapy using irradiation with glucocorticoids or doxorubicin.
Kruit A; Reyes-Moreno C; Newling DW; Geldof A; Koutsilieris M
Anticancer Res; 1999; 19(4B):3153-6. PubMed ID: 10652605
[TBL] [Abstract][Full Text] [Related]
35. [Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].
Yu WJ; Wang YW; Xie ZG; You JF; Wang JL; Cui XL; Pei F; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):88-94. PubMed ID: 20388373
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
37. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
[TBL] [Abstract][Full Text] [Related]
38. PC-1/PrLZ contributes to malignant progression in prostate cancer.
Zhang H; Wang J; Pang B; Liang RX; Li S; Huang PT; Wang R; Chung LW; Zhau HE; Huang C; Zhou JG
Cancer Res; 2007 Sep; 67(18):8906-13. PubMed ID: 17875733
[TBL] [Abstract][Full Text] [Related]
39. Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines.
Venkateswaran V; Klotz LH; Fleshner NE
Cancer Res; 2002 May; 62(9):2540-5. PubMed ID: 11980647
[TBL] [Abstract][Full Text] [Related]
40. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
